质母细胞瘤的条件生存:随着时间的推移,预后因素的演变
Timothy Mueller1,2,3,4, Flavio Vasella1, Julia Velz1,4
1Department of Neurosurgery, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.
International journal of cancer
|December 31, 2025
概括
质母细胞瘤的条件生存分析表明,虽然残留瘤体积影响早期预后,但年龄和MGMT促进剂甲基化仍然是关键的长期预测因素. 这些见解可以改善临床试验的患者分层.
科学领域:
- 神经瘤学神经瘤学
- 对生存分析的分析.
- 癌症预后 癌症预后
背景情况:
- 人们对质母细胞瘤的预后演变和预后因素动态的了解很少.
- 关于质母细胞瘤预后因素的时间数据很少.
- 条件生存 (CS) 提供了对随时间推移的预后的见解.
研究的目的:
- 分析IDH野生型质母细胞瘤的预后因素的时间演变.
- 在多个里程碑时间评估12个月条件生存 (CS).
- 确定影响不同疾病阶段生存的预后因素.
主要方法:
- 从前性收集的注册表 (2008-2017) 中分析了315名IDH野生型质母细胞瘤患者.
- 在里程碑时间 (12个月的CS计算 (0,6,12,18,24个月的诊断后).
- 评估基线预后因素,包括年龄,瘤体积区,MGMT促进物甲基化和KPS.
主要成果:
- 诊断时12个月的CS估计值 (s=0) 为0.51,在12个月后降至0.41,然后在24个月后增加到0.56.
- 诊断时的预后因素包括年龄>60,手术前瘤边缘体积>20厘米3,没有MGMT甲基化,KPS≥70,残留瘤>1厘米3,或仅进行活检.
- 剩余瘤体积显著影响了早期生存,而MGMT促进剂甲基化和年龄仍然是长期的重要预测因素.
结论:
- 预后因素的意义在质母细胞瘤进展过程中演变.
- 在最初的手术后期,残留的瘤体积至关重要.
- MGMT促进物甲基化和年龄是质母细胞瘤长期存活的持续预测因素.
更多相关视频
06:32Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
8.2K
10:58Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
Published on: February 22, 2015
13.4K
相关概念视频
01:21Cancer Survival Analysis
626
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
626
02:07Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K